icad — Company Overview, News & Financial Data

iCAD (NASDAQ:ICAD) is a technology company focused on providing innovative cancer detection and therapy solutions. It operates primarily in the healthcare sector, offering a range of products aimed at improving the accuracy, efficiency, and effectiveness of cancer screening and treatment. iCAD's projects span advanced imaging and radiation therapy technologies intended to support healthcare professionals in diagnosing and treating breast, prostate, and other cancers. The company’s objectives include leveraging artificial intelligence and deep learning to enhance early detection rates and optimize therapeutic outcomes, thereby improving patient care and survival rates. Through ongoing research and development, iCAD aims to stay at the forefront of technological advancements in the oncology field, contributing to the global fight against cancer.